Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder

about

Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder

Item

http://www.wikidata.org/entity/Q57492671

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Relationship between buprenorp ...... ients with opioid use disorder

@en

Relationship between buprenorp ...... ients with opioid use disorder

@nl

type

Item

label

Relationship between buprenorp ...... ients with opioid use disorder

@en

Relationship between buprenorp ...... ients with opioid use disorder

@nl

prefLabel

Relationship between buprenorp ...... ients with opioid use disorder

@en

Relationship between buprenorp ...... ients with opioid use disorder

@nl

P1476

Relationship between buprenorp ...... ients with opioid use disorder

@en

P2093

Bernd A Wollschlaeger

http://www.w3.org/2001/XMLSchema#string

Leslie B Montejano

http://www.w3.org/2001/XMLSchema#string

Naoko A Ronquest

http://www.w3.org/2001/XMLSchema#string

Tina M Willson

http://www.w3.org/2001/XMLSchema#string

Vijay R Nadipelli

http://www.w3.org/2001/XMLSchema#string

P2860

Measuring diagnoses: ICD code accuracy

Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions.

Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Substance Use Related Stigma: What we Know and the Way Forward.

Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.

Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.

Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History

Office-based buprenorphine treatment for opioid-dependent patients.

American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.

P304

59-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/SAR.S150253

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30310349

http://www.w3.org/2001/XMLSchema#string

P921

opioid

P932

6165853

http://www.w3.org/2001/XMLSchema#string